143 related articles for article (PubMed ID: 12640983)
61. Bubble-free. French doctors score a gene-therapy triumph.
Gorman C
Time; 2000 May; 155(19):66. PubMed ID: 11765516
[No Abstract] [Full Text] [Related]
62. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
Gaspar HB; Howe S; Thrasher AJ
Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
[TBL] [Abstract][Full Text] [Related]
63. Gene therapy: beyond 2000.
Verma IM
Mol Ther; 2000 Jun; 1(6):493. PubMed ID: 10933971
[No Abstract] [Full Text] [Related]
64. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
65. [Differences in the MLV and HIV-1 integration sites could be important for gene therapy].
Jeanteur P
Bull Cancer; 2003; 90(8-9):671. PubMed ID: 14626239
[No Abstract] [Full Text] [Related]
66. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
67. [Current status and future prospective of gene therapy].
Kaneda Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():469-74. PubMed ID: 16416836
[No Abstract] [Full Text] [Related]
68. Clinical applications of gene therapy.
Carter B; Kohn DB
Curr Opin Mol Ther; 2000 Aug; 2(4):360-1. PubMed ID: 11249765
[No Abstract] [Full Text] [Related]
69. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis.
Cichutek K
Dev Biol (Basel); 2006; 123():29-34; discussion 55-73. PubMed ID: 16566434
[No Abstract] [Full Text] [Related]
70. Gene therapy of severe combined immunodeficiencies: from mice to humans.
Hacein-Bey S; Yates F; de Villartay JP; Fischer A; Cavazzana-Calvo M
Neth J Med; 2002 Aug; 60(7):299-301. PubMed ID: 12430581
[No Abstract] [Full Text] [Related]
71. Gene therapy rising?
Hoag H
Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
[No Abstract] [Full Text] [Related]
72. [Gene therapy of children with X-linked severe combined immune deficiency: efficiency and complications].
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Med Sci (Paris); 2004 Jan; 20(1):115-7. PubMed ID: 14770374
[No Abstract] [Full Text] [Related]
73. [A third tumor following SCID gene therapy].
Winckler T
Pharm Unserer Zeit; 2005; 34(3):184-5. PubMed ID: 15940949
[No Abstract] [Full Text] [Related]
74. [Gene therapy is probably going to fulfil expectations. Not yet a risk-free therapeutic method].
Smith CI
Lakartidningen; 2001 Feb; 98(9):924-6. PubMed ID: 11292968
[No Abstract] [Full Text] [Related]
75. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
76. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
77. Update on gene therapy for hereditary hematological disorders.
Herzog RW; Arruda VR
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
[TBL] [Abstract][Full Text] [Related]
78. Gene therapy.
Anderson WF
Sci Am; 1995 Sep; 273(3):124-8. PubMed ID: 7652529
[No Abstract] [Full Text] [Related]
79. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
80. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
